| 1 | Ministry of Food and Drug Safety | Graduate program in regulatory science focusing on the effectiveness of drugs and biologics | 2021-05-01 | 2025-12-31 |
| 2 | National Research Foundation of Korea | Colistin treatment optimization for pneumonia based on target tissue distribution profile through pharmacometric study combined with data mining | 2021-06-01 | 2024-05-31 |
| 3 | Korea Health Industry Development Institute | Korean Medicine Priority Research Center for Degenerative Joint Diseases | 2020-08-19 | 2021-03-31 |
| 4 | Korea Foundation for the Advancement of Science and Creativity | Analysis of risk factors for mortality using 10-year drug adverse event report (KAERS) data and prediction of future mortality | 2020-06-01 | 2020-11-30 |
| 5 | National Research Foundation of Korea | Development of an Algorithm for Early Detection of Cholangiocarcinoma Based on Modeling and Data Mining Using Bile-derived Novel Biomarkers | 2019-03-01 | 2022-02-28 |
| 6 | National Research Foundation of Korea | Optimization of colistin treatment outcome based on dried blood spot through pharmacometrics study combined with data mining in critically ill patients infected by multidrug-resistant organisms | 2018-03-01 | 2021-02-28 |
| 7 | Korea Health Industry Development Institute | Development of Korean clinical practice guidelines of vertigo(dizziness) | 2018-01-01 | 2020-12-31 |
| 8 | National Research Foundation of Korea | Data mining-based pharmacometric study to optimize antimicrobial treatment outcomes in patients with acute biliary tract infections | 2017-03-01 | 2020-02-29 |
| 9 | MedPacto, Inc. | Clinical pharmacokinetic modeling study of TEW7197 anticancer drug | 2017 | 2019 |
| 10 | National Institute of Food and Drug Safety Evaluation | Development and optimization of DUR criteria | 2017-08-01 | 2018-02-28 |
| 11 | Korea Health Industry Development Institute | Cost-Effectiveness analysis of Korean Medicine Treatments for Parkinson's Disease | 2016-08-02 | 2020-12-31 |
| 12 | Genexine | Group 2date PK/PD modeling & simulation of GX-H9 for adult patients Phase 2 clinical trial | 2016-01-21 | 2016-05-25 |
| 13 | National Institute of Food and Drug Safety Evaluation | Research and analysis project to prepare scientific guidelines (draft) for extrapolation of biosimilar indications | 2015-04-01 | 2016-11-30 |
| 14 | Kyung Hee University | A Study on Optimization of Linezolid Antibiotic Dose/Dosage in Obese and Severe Obese Patients Using Population Pharmacokinetics | 2015-03-01 | 2016-11-30 |
| 15 | ASCPT | Young Investigator Award; Alternative requirements of obese patients in model-based linezolid dosing regimens for optimal therapy in comparison to non-obese patients | 2013 | 2014 |
